Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plumino is a Japanese biotechnology company specializing in the production of high-value functional proteins through advanced precision fermentation. The company's primary focus is the development of recombinant human lactoferrin, a bioactive protein essential for immune health and infant development that is traditionally scarce and expensive to produce. By leveraging engineered microbial hosts, Plumino aims to provide a sustainable, animal-free, and scalable supply of human-identical proteins for the pharmaceutical, nutraceutical, and infant formula industries. The company is positioned at the intersection of life sciences and food technology, addressing global supply chain constraints for critical nutritional components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plumino Precision Fermentation Japan.